89 related articles for article (PubMed ID: 20298767)
1. Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes.
Ishihara A; Yamauchi M; Kusano H; Mimura Y; Nakakura M; Kamiya M; Katagiri A; Kawano M; Nemoto H; Suzawa T; Yamasaki M
Int J Pharm; 2010 May; 391(1-2):237-43. PubMed ID: 20298767
[TBL] [Abstract][Full Text] [Related]
2. A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity.
Ishihara A; Yamauchi M; Tsuchiya T; Mimura Y; Tomoda Y; Katagiri A; Kamiya M; Nemoto H; Suzawa T; Yamasaki M
J Biomater Sci Polym Ed; 2012; 23(16):2055-68. PubMed ID: 22054261
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
4. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
Ishida T; Atobe K; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
[TBL] [Abstract][Full Text] [Related]
5. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
[TBL] [Abstract][Full Text] [Related]
6. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum.
Han HD; Shin BC; Choi HS
Eur J Pharm Biopharm; 2006 Jan; 62(1):110-6. PubMed ID: 16183268
[TBL] [Abstract][Full Text] [Related]
8. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
Wang XY; Ishida T; Ichihara M; Kiwada H
J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.
Shehata T; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Jul; 359(1-2):272-9. PubMed ID: 18486370
[TBL] [Abstract][Full Text] [Related]
10. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen TM; Mehra T; Hansen C; Chin YC
Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
12. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
[TBL] [Abstract][Full Text] [Related]
13. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.
Ishida T; Ichikawa T; Ichihara M; Sadzuka Y; Kiwada H
J Control Release; 2004 Mar; 95(3):403-12. PubMed ID: 15023452
[TBL] [Abstract][Full Text] [Related]
14. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition.
Furumoto K; Yokoe J; Ogawara K; Amano S; Takaguchi M; Higaki K; Kai T; Kimura T
Int J Pharm; 2007 Feb; 329(1-2):110-6. PubMed ID: 17000067
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
16. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.
Awasthi VD; Garcia D; Klipper R; Goins BA; Phillips WT
J Pharmacol Exp Ther; 2004 Apr; 309(1):241-8. PubMed ID: 14718581
[TBL] [Abstract][Full Text] [Related]
17. An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes.
Crielaard BJ; Yousefi A; Schillemans JP; Vermehren C; Buyens K; Braeckmans K; Lammers T; Storm G
J Control Release; 2011 Dec; 156(3):307-14. PubMed ID: 21803084
[TBL] [Abstract][Full Text] [Related]
18. Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines.
Gabizon A; Chemla M; Tzemach D; Horowitz AT; Goren D
J Drug Target; 1996; 3(5):391-8. PubMed ID: 8866658
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
